Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

NCT04419337 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Stroke

Interventions

DRUG: Metformin plus Pioglitazone plus an SGLT2 inhibitor

Sponsor

Chang Gung Memorial Hospital

Collaborators

[object Object]
[object Object]
[object Object]